Atlas Trials

Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

Clinical trial NCT00355095 · COMPLETED

Trial details

NCT number
NCT00355095
Sponsor
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Optic Neuritis
Start date
2006-08-01
Primary completion
2011-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.